Project Search Results

Select

Research Categorization

Operator
Operator

Project Details

Operator
Operator

Contact Researcher and Awardee Organization

Operator
Operator

Funding Organization

Operator
Operator
Operator
Operator
ListGraphMap
Displaying 1 - 10 of 61 Projects
Project # Contact PI Funding Organization Fiscal Year
Phase 1 Study of a Novel Device Reducing Vascular Contributions to Dementia
PTCG-20-694888 Celermajer, David Alzheimer's Association 2020
Exercise as a primer for excitatory stimulation in VCIND (EXPRESS-V)
PTCG-20-700751 Lanctôt, Krista Alzheimer's Association 2020
Phase 2 study of CNS sGC stimulation in AD with vascular features
PTCG-20-707481 Winrow, Christopher Alzheimer's Association 2020
AFTD Patient-Focused Drug Development Meeting with the FDA
ADDF-10 Dickinson, Susan Alzheimer's Drug Discovery Foundation 2020
Development of a PIKFYVE antisense oligonucleotide (ASO) treatment for FTD
ADDF-2 Chang, Wen-Hsuan Alzheimer's Drug Discovery Foundation 2020
Preclinical efficacy study for antibody therapy in C9orf72 FTD/ALS mice
ADDF-30 Edbauer, Dieter Alzheimer's Drug Discovery Foundation 2020
Lead Optimization of Novel Site-Selective Blockers of Mitochondrial Complex III ROS as FTD Therapeutics
ADDF-4 Orr, Anna Alzheimer's Drug Discovery Foundation 2020
Guiding next steps for SPRINT-MIND implementation: Identifying high-benefit subgroups and comparative effects of ARB- vs. ACEI-based regimens
1R01AG065805-01A1 BRESS, ADAM P NIA 2020
Formulation of a Novel Therapeutic for Treating Cognitive Impairment in Patients at-risk for Alzheimer's Disease-Related Dementias and Vascular Contributions to Cognitive Impairment
1R43AG069524-01 OSSANNA, NINA NIA 2020
IND Enabling Studies for RASRx 1902; a novel Mas receptor agonist; for treatment of cognitive impairment in patients at risk for Alzheimer's disease.
1U01AG063768-01A1 RODGERS, KATHLEEN E. NIA 2020